Bellus Stock Story


USD 11.29  0.14  1.22%   

Bellus Health Tangible Assets Book Value per Share are comparatively stable at the moment as compared to the past year. Bellus Health reported Tangible Assets Book Value per Share of 3.95 in 2021. Net Cash Flow or Change in Cash and Cash Equivalents is likely to gain to about 108.3 M in 2022, whereas Earnings before Tax are likely to drop (73.3 M) in 2022. While some baby boomers are getting worried about healthcare space, it is reasonable to review Bellus Health. We will evaluate if Bellus Health shares are reasonably priced going into June. In this post, I will also go over a few different drivers affecting Bellus Health's products and services, and explain how it may impact Bellus Health private investors.
Published over two months ago
View all stories for Bellus Health | View All Stories

Bellus Health (NASDAQ:BLU) continues to gain

This firm's average rating is Buy from 8 analysts.
We provide trade advice to complement the prevailing expert consensus on Bellus Health. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.

How important is Bellus Health's Liquidity

Bellus Health financial leverage refers to using borrowed capital as a funding source to finance Bellus Health ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Bellus Health financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Bellus Health's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Bellus Health, but it might be worth checking our own buy vs. sell analysis

What did Bellus Health file with SEC?

The SEC filings are financial statements or other formal documents of Bellus Health that are regularly submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make SEC filings and fintech professionals rely on these filings for information about companies they are evaluating for investment purposes. Please note, most SEC filings are available online through the SEC's EDGAR database.
Please check here for more information.
Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Bellus shareholders may or may not be submitted as SEC does not always require it.
10th of August 2022
Other Events
14th of February 2022
Unclassified Corporate Event
Please note, although all public domestic companies are required to submit their filings via EDGAR, not all public companies are available through our service. Also, keep in mind that the actual annual reports to Bellus shareholders may or may not be submitted as SEC does not always require it.

An Additional Perspective On Bellus Health

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bellus Health has an asset utilization ratio of 0.0407 percent. This implies that the company is making $4.07E-4 for each dollar of assets. An increasing asset utilization means that Bellus Health is more efficient with each dollar of assets it utilizes for everyday operations.
 2019 2020 2021 2022 (projected)
Current Assets94.25 M102.31 M258.2 M278.59 M
Total Assets96.37 M153.11 M309.6 M334.04 M

Will Bellus Health growth be sustainable after the gain?

The risk adjusted performance is down to 0.18 as of today. Bellus Health exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Bellus Health individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Bellus Health future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bellus Health's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bellus Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Bellus Health Implied Volatility

Bellus Health's implied volatility exposes the market's sentiment of Bellus Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bellus Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bellus Health stock will not fluctuate a lot when Bellus Health's options are near their expiration.

Our Conclusion on Bellus Health

Whereas some companies under the biotechnology industry are still a bit expensive, Bellus Health may offer a potential longer-term growth to private investors. With an optimistic outlook on your 90 days horizon, it may be a good time to take in new shares of Bellus or increase your existing holdings in the Stock as it seems the potential growth has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Bellus Health.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Bellus Health. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to